BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28834965)

  • 1. Response Evaluation of Malignant Liver Lesions After TACE/SIRT: Comparison of Manual and Semi-Automatic Measurement of Different Response Criteria in Multislice CT.
    Höink AJ; Schülke C; Koch R; Löhnert A; Kammerer S; Fortkamp R; Heindel W; Buerke B
    Rofo; 2017 Nov; 189(11):1067-1075. PubMed ID: 28834965
    [No Abstract]   [Full Text] [Related]  

  • 2. MSCT follow-up in malignant lymphoma: comparison of manual linear measurements with semi-automated lymph node analysis for therapy response classification.
    Weßling J; Puesken M; Koch R; Kohlhase N; Persigehl T; Mesters R; Heindel W; Buerke B
    Rofo; 2012 Sep; 184(9):795-804. PubMed ID: 22618478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.
    Bonekamp D; Bonekamp S; Halappa VG; Geschwind JF; Eng J; Corona-Villalobos CP; Pawlik TM; Kamel IR
    Eur J Radiol; 2014 Mar; 83(3):487-96. PubMed ID: 24387824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-automatic software increases CT measurement accuracy but not response classification of colorectal liver metastases after chemotherapy.
    van Kessel CS; van Leeuwen MS; Witteveen PO; Kwee TC; Verkooijen HM; van Hillegersberg R
    Eur J Radiol; 2012 Oct; 81(10):2543-9. PubMed ID: 22264447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy response evaluation of malignant lymphoma in a multicenter study: comparison of manual and semiautomatic measurements in CT.
    Weßling J; Schülke C; Koch R; Kohlhase N; Wassenaar L; Mesters R; Höink AJ; D Anastasi M; Karpitschka M; Fabel M; Wulff AM; Pinto dos Santos D; Kiessling A; Graser A; Bornemann L; Dicken V; Heindel W; Buerke B
    Rofo; 2014 Aug; 186(8):768-79. PubMed ID: 24497088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
    Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
    J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
    Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
    J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?
    Zhao Y; Duran R; Bai W; Sahu S; Wang W; Kabus S; Lin M; Han G; Geschwind JF
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):433-442. PubMed ID: 29086058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of manual and semi-automatic measuring techniques in MSCT scans of patients with lymphoma: a multicentre study.
    Höink AJ; Weßling J; Koch R; Schülke C; Kohlhase N; Wassenaar L; Mesters RM; D'Anastasi M; Fabel M; Wulff A; Pinto dos Santos D; Kießling A; Graser A; Dicken V; Karpitschka M; Bornemann L; Heindel W; Buerke B
    Eur Radiol; 2014 Nov; 24(11):2709-18. PubMed ID: 25192795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization.
    Monsky WL; Kim I; Loh S; Li CS; Greasby TA; Deutsch LS; Badawi RD
    AJR Am J Roentgenol; 2010 Nov; 195(5):1220-30. PubMed ID: 20966331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-automated measurement of hyperdense, hypodense and heterogeneous hepatic metastasis on standard MDCT slices. Comparison of semi-automated and manual measurement of RECIST and WHO criteria.
    Keil S; Behrendt FF; Stanzel S; Sühling M; Koch A; Bubenzer J; Mühlenbruch G; Mahnken AH; Günther RW; Das M
    Eur Radiol; 2008 Nov; 18(11):2456-65. PubMed ID: 18523775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
    Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
    J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants.
    Bargellini I; Bozzi E; Campani D; Carrai P; De Simone P; Pollina L; Cioni R; Filipponi F; Bartolozzi C
    Eur J Radiol; 2013 May; 82(5):e212-8. PubMed ID: 23332890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
    Sahu S; Schernthaner R; Ardon R; Chapiro J; Zhao Y; Sohn JH; Fleckenstein F; Lin M; Geschwind JF; Duran R
    Radiology; 2017 Jun; 283(3):883-894. PubMed ID: 27831830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of RECIST, mRECIST, and choi criteria for early response evaluation of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads.
    Yeo DM; Choi JI; Lee YJ; Park MY; Chun HJ; Lee HG
    J Comput Assist Tomogr; 2014; 38(3):391-7. PubMed ID: 24681857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Choi SJ; Kim J; Seo J; Kim HS; Lee JM; Park H
    Abdom Imaging; 2014 Jun; 39(3):518-25. PubMed ID: 24519566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
    Wang Z; Chapiro J; Schernthaner R; Duran R; Chen R; Geschwind JF; Lin M
    Acad Radiol; 2015 Jul; 22(7):840-5. PubMed ID: 25863795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.
    Tacher V; Lin M; Duran R; Yarmohammadi H; Lee H; Chapiro J; Chao M; Wang Z; Frangakis C; Sohn JH; Maltenfort MG; Pawlik T; Geschwind JF
    Radiology; 2016 Jan; 278(1):275-84. PubMed ID: 26131913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric response classification in metastatic solid tumors on MSCT: initial results in a whole-body setting.
    Wulff AM; Fabel M; Freitag-Wolf S; Tepper M; Knabe HM; Schäfer JP; Jansen O; Bolte H
    Eur J Radiol; 2013 Oct; 82(10):e567-73. PubMed ID: 23827800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.